< 返回主頁

Oseltamivir resistance mutation N294S in human influenza A(H5N1) virus in Egypt

by | Nov 20, 2024 | Scientific reports, Virology, Pathophysiology

歷史重覆,禽流抗藥

WHO recommends using Tamiflu (oseltamivir) at 75 mg twice daily to treat A(H5N1) infections and supports stockpiling in advance of a pandemic.

Oseltamivir resistance in H1N1 resulting from H274Y and N294S mutation is now widespread, as published in 2009, 25 years ago.

Read more click here